  See all
 |
Articles: Vaccine/Immunotherapy |
Response to a Monovalent 2009 Influenza A (H1N1) Vaccine
New England Journal of Medicine, 12/17/09
A Novel Influenza A (H1N1) Vaccine in Various Age Groups
New England Journal of Medicine, 12/17/09 Efficacy and Safety of Pentavalent Human-Bovine Reassortant Rotavirus Vaccine When Administered With Greater Than 10 Weeks Between Doses
The Pediatric Infectious Disease Journal, 12/17/09 Influenza Vaccination in Liver Transplant Recipients
Transplantation, 12/17/09 A virosomal formulated Her-2/neu multi-peptide vaccine induces Her-2/neu-specific immune responses in patients with metastatic breast cancer: a phase I study
Breast Cancer Research and Treatment, 12/17/09 Trial of 2009 Influenza A (H1N1) Monovalent MF59-Adjuvanted Vaccine
New England Journal of Medicine, 12/17/09 Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials
The Lancet - Early Online Publication, 12/16/09 Tetravalent A-beta-1–15 vaccine reduces TCR-positive cell infiltration and up-regulates p75 in Tg2576 brains compared to A-beta-42 vaccine
Journal of Neuroimmunology, 12/16/09 Novel Approach to the Formulation of an Epstein-Barr Virus Antigen-Based Nasopharyngeal Carcinoma Vaccine
Journal of Virology, 12/16/09 Mucosally induced Immunological Tolerance, Regulatory T Cells and the Adjuvant Effect by Cholera Toxin B Subunit
Scandinavian Journal of Immunology, 12/16/09 Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial
The Lancet - Early Online Publication, 12/16/09 Safety and immunogenicity of a 2009 pandemic influenza A H1N1 vaccine when administered alone or simultaneously with the seasonal influenza vaccine for the 2009—10 influenza season: a multicentre, randomised controlled trial
The Lancet - Early Online Publication, 12/16/09 Reactogenicity and Immunogenicity of Combined Haemophilus influenzae Type b-Meningococcal Serogroup C Conjugate Vaccine Booster Dose Coadministered With Measles, Mumps, and Rubella VaccineHib-MenC-TT Booster With Routine MMR Vaccine
The Pediatric Infectious Disease Journal, 12/16/09 Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6·4 years
The Lancet, 12/15/09 Reactive antibodies against bacillus Calmette-Guerin heat-shock protein-65 potentially predict the outcome of immunotherapy for high-grade transitional cell carcinoma of the bladder
Cancer, 12/15/09 Zoster vaccination: A new opportunity for adult immunization
Canadian Journal of Infectious Diseases, 12/15/09 Description of an Influenza Vaccination Campaign and Use of a Randomized Survey to Determine Participation Rates
Infection Control and Hospital Epidemiology, 12/15/09 Pandemic influenza is a strong motivator for participation in vaccine clinical trials among HIV-positive Canadian adults
Canadian Journal of Infectious Diseases, 12/15/09 Cost-effectiveness of human papilloma virus vaccination in Iceland
Acta Obstetricia et Gynecologica Scandinavica, 12/15/09 CpG-enhanced CD8+ T-cell responses to peptide immunization are severely inhibited by B cells
European Journal of Immunology, 12/15/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Allergy, Clinical Immunology, Annals of Allergy, Asthma, and Immunology
more...
|
250 Available Pages
|
|
